Global Advil Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Advil Market Research Report 2024
Advil is a brand of medication in the nonsteroidal anti-inflammatory drug (NSAID) class that is used for treating pain, fever, and inflammation. This includes painful menstrual periods, migraines, and rheumatoid arthritis. It may also be used to close a patent ductus arteriosus in a premature baby. It can be used by mouth or intravenously. It typically begins working within an hour. Common side effects include heartburn and a rash. Compared to other NSAIDs, it may have other side effects such as gastrointestinal bleeding. It increases the risk of heart failure, kidney failure, and liver failure. At low doses, it does not appear to increase the risk of heart attack; however, at higher doses it may. Advil can also worsen asthma. While it is unclear whether it is safe in early pregnancy, it appears to be harmful in later pregnancy and therefore is not recommended. Like other NSAIDs, it works by inhibiting the production of prostaglandins by decreasing the activity of the enzyme cyclooxygenase (COX). Advil is a weaker anti-inflammatory agent than other NSAIDs.
According to Mr Accuracy reports new survey, global Advil market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Advil market research.
Key manufacturers engaged in the Advil industry include Pfizer, BASF, Tremblay Jean, Johnson & Johnson, Pacific Pharmaceutical, Health Meds, Wyeth, Grand Fly Display Product and Pharma Mango, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Advil were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Advil market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Advil market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Pfizer
BASF
Tremblay Jean
Johnson & Johnson
Pacific Pharmaceutical
Health Meds
Wyeth
Grand Fly Display Product
Pharma Mango
Catalent
Glaxosmithkline
Interphil
Cumberland Pharmaceuticals
Alveda Pharmaceuticals
Sandor Medicaids
Gloria Pharmaceuticals
Xinhua Pharmaceutical
Segment by Type
USP Grade
EP Grade
Contract Manufacturing Organization
Pharmaceutical Company
Others
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Advil report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
According to Mr Accuracy reports new survey, global Advil market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Advil market research.
Key manufacturers engaged in the Advil industry include Pfizer, BASF, Tremblay Jean, Johnson & Johnson, Pacific Pharmaceutical, Health Meds, Wyeth, Grand Fly Display Product and Pharma Mango, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Advil were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Advil market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Advil market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Pfizer
BASF
Tremblay Jean
Johnson & Johnson
Pacific Pharmaceutical
Health Meds
Wyeth
Grand Fly Display Product
Pharma Mango
Catalent
Glaxosmithkline
Interphil
Cumberland Pharmaceuticals
Alveda Pharmaceuticals
Sandor Medicaids
Gloria Pharmaceuticals
Xinhua Pharmaceutical
Segment by Type
USP Grade
EP Grade
Segment by Application
Contract Manufacturing Organization
Pharmaceutical Company
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Advil report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source